These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26485987)

  • 1. [Influence of Tumor Microenvironment of Hepatocellular Carcinoma on the Proliferation of Vascular Endothelial Cells and Vascular Angiogenesis Ability].
    Xia Q; Yin H; Shen Y; Liu J; Yan Z; Hong J; Zhou F; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):612-7. PubMed ID: 26485987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model.
    Chiew GGY; Fu A; Perng Low K; Qian Luo K
    Sci Rep; 2015 Jun; 5():10801. PubMed ID: 26053957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
    Huang B; Huang M; Li Q
    Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.
    Cheng CC; Chao WT; Shih JH; Lai YS; Hsu YH; Liu YH
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):143-153. PubMed ID: 33860837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
    Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
    Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
    Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
    Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of low molecular weight heparin on the secretion of vascular endothelial growth factor by tumor cells in vitro].
    Sun Z; Hu ZL; Ning XH; Zhou JF; Shao YJ; Duan JH; Yang XD; Bai CM
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):826-30. PubMed ID: 20137346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study.
    Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G
    Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
    Wang H; Zhang C; Chi H; Meng Z
    Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
    Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y
    Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A.
    Lu Y; Lin N; Chen Z; Xu R
    Mol Med Rep; 2015 Jan; 11(1):691-7. PubMed ID: 25333351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis.
    Wang F; Fei H; Qi B; Yao S; Chang Z
    Mol Cell Biochem; 2012 May; 364(1-2):165-71. PubMed ID: 22209835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.